Merck 4Q powered by cancer treatment sales
ABC News -

Merck is reporting better than expected profits for the fourth quarter with revenue jumping 4.6 percent. The drugmaker swung to a fourth-quarter net income of $1.83 billion, or 69 cents per share. Earnings, adjusted for costs related to mergers and acquisitions and non-recurring costs, were

Read this story at , ,


Related Articles